Literature DB >> 18439408

Multiple actions of spinophilin regulate mu opioid receptor function.

Joanna J Charlton1, Patrick B Allen, Kassi Psifogeorgou, Sumana Chakravarty, Ivone Gomes, Rachael L Neve, Lakshmi A Devi, Paul Greengard, Eric J Nestler, Venetia Zachariou.   

Abstract

Spinophilin, a dendritic spine-enriched scaffold protein, modulates synaptic transmission via multiple functions mediated by distinct domains of the protein. Here, we show that spinophilin is a key modulator of opiate action. Knockout of the spinophilin gene causes reduced sensitivity to the analgesic effects of morphine and early development of tolerance but a higher degree of physical dependence and increased sensitivity to the rewarding actions of the drug. At the cellular level, spinophilin associates with the mu opioid receptor (MOR) in striatum and modulates MOR signaling and endocytosis. Activation of MOR by opiate agonists such as fentanyl and morphine promotes these events, which feedback to suppress MOR responsiveness. Our findings support a potent physiological role of spinophilin in regulating MOR function and provide a potential new target for the treatment of opiate addiction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439408      PMCID: PMC3115895          DOI: 10.1016/j.neuron.2008.02.006

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  45 in total

1.  Local gene knockdown in the brain using viral-mediated RNA interference.

Authors:  Jonathan D Hommel; Robert M Sears; Dan Georgescu; Diana L Simmons; Ralph J DiLeone
Journal:  Nat Med       Date:  2003-11-23       Impact factor: 53.440

Review 2.  Mu opioid receptor: a gateway to drug addiction.

Authors:  Candice Contet; Brigitte L Kieffer; Katia Befort
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

3.  Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures.

Authors:  Seksiri Arttamangkul; Maria Torrecilla; Kazuto Kobayashi; Hideyuki Okano; John T Williams
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

4.  Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.

Authors:  P B Allen; V Zachariou; P Svenningsson; A C Lepore; D Centonze; C Costa; S Rossi; G Bender; G Chen; J Feng; G L Snyder; G Bernardi; E J Nestler; Z Yan; P Calabresi; P Greengard
Journal:  Neuroscience       Date:  2006-07-07       Impact factor: 3.590

5.  An essential role for DeltaFosB in the nucleus accumbens in morphine action.

Authors:  Venetia Zachariou; Carlos A Bolanos; Dana E Selley; David Theobald; Michael P Cassidy; Max B Kelz; Tamara Shaw-Lutchman; Olivier Berton; Laura J Sim-Selley; Ralph J Dileone; Arvind Kumar; Eric J Nestler
Journal:  Nat Neurosci       Date:  2006-01-15       Impact factor: 24.884

6.  Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization.

Authors:  Hui Zhao; Horace H Loh; P Y Law
Journal:  Mol Pharmacol       Date:  2006-01-13       Impact factor: 4.436

7.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

8.  G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.

Authors:  Gregory W Terman; Wenzhen Jin; Young-Pyo Cheong; Janet Lowe; Marc G Caron; Robert J Lefkowitz; Charles Chavkin
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

9.  Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference.

Authors:  Emmanuel Valjent; Anne-Gaëlle Corbillé; Jesus Bertran-Gonzalez; Denis Hervé; Jean-Antoine Girault
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

10.  Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia.

Authors:  Cheryl L Marker; Markus Stoffel; Kevin Wickman
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

View more
  42 in total

Review 1.  Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications.

Authors:  Mark von Zastrow
Journal:  Drug Alcohol Depend       Date:  2010-03-24       Impact factor: 4.492

2.  A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Authors:  Kassi Psifogeorgou; Kassi Psigfogeorgou; Dimitra Terzi; Maria Martha Papachatzaki; Artemis Varidaki; Deveroux Ferguson; Stephen J Gold; Venetia Zachariou
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

3.  RGS9-2: probing an intracellular modulator of behavior as a drug target.

Authors:  John R Traynor; Dimitra Terzi; Barbara J Caldarone; Venetia Zachariou
Journal:  Trends Pharmacol Sci       Date:  2009-02-09       Impact factor: 14.819

Review 4.  Membrane functional organisation and dynamic of mu-opioid receptors.

Authors:  André Lopez; Laurence Salomé
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

Review 5.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.

Authors:  Sevasti Gaspari; Maria M Papachatzaki; Ja Wook Koo; Fiona B Carr; Maria-Efstratia Tsimpanouli; Eugenia Stergiou; Rosemary C Bagot; Deveroux Ferguson; Ezekiell Mouzon; Sumana Chakravarty; Karl Deisseroth; Mary Kay Lobo; Venetia Zachariou
Journal:  Neuropsychopharmacology       Date:  2014-02-24       Impact factor: 7.853

Review 7.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

8.  Knockout of spinophilin, an endogenous antagonist of arrestin-dependent alpha2-adrenoceptor functions, enhances receptor-mediated antinociception yet does not eliminate sex-related differences.

Authors:  Subodh Nag; Qin Wang; Lee E Limbird; Sukhbir S Mokha
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

9.  The association of spinophilin with disks large-associated protein 3 (SAPAP3) is regulated by metabotropic glutamate receptor (mGluR) 5.

Authors:  Cameron W Morris; Darryl S Watkins; Asma B Salek; Michael C Edler; Anthony J Baucum
Journal:  Mol Cell Neurosci       Date:  2018-06-14       Impact factor: 4.314

10.  Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Authors:  Jay Jin; Saranya Kittanakom; Victoria Wong; Beverly A S Reyes; Elisabeth J Van Bockstaele; Igor Stagljar; Wade Berrettini; Robert Levenson
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.